While the Buy rating suggests that UBS remains optimistic about Oracle's future performance, the reduction in the price target may reflect a more cautious view on the company's growth potential or market conditions. This could lead to a neutral short-term impact on the stock as the positive sentiment from the Buy rating is counterbalanced by the lowered price target.